Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Applied Therapeutics Inc (APLT)

Applied Therapeutics Inc (APLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Applied Therapeutics Inc 545 5TH AVENUE SUITE 1400 NEW YORK NY 10017 USA

www.appliedtherapeutics.com Employees: 25 P: 212-220-9226

Description:

Applied Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing drug candidates for unmet medical need. The company's product candidate consists of AT-001, for the treatment of Diabetic Cardiomyopathy; AT-007, for the treatment of Galactosemia and AT-003, for the treatment of diabetic retinopathy which are in clinical stage. Applied Therapeutics Inc. is based in New York, United States.

Key Statistics

Overview:

Market Capitalization, $K 935,847
Enterprise Value, $K 885,947
Shares Outstanding, K 114,267
Annual Sales, $ 9,990 K
Annual Net Income, $ -119,760 K
Last Quarter Sales, $ 140 K
Last Quarter Net Income, $ 2,900 K
EBIT, $ -78,040 K
EBITDA, $ -75,570 K
60-Month Beta 2.04
% of Insider Shareholders 8.60%
% of Institutional Shareholders 98.31%
Float, K 104,440
% Float 91.40%
Short Volume Ratio 0.18

Growth:

1-Year Return 268.09%
3-Year Return -52.08%
5-Year Return -38.24%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.13 on 08/07/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -1.09
EPS Growth vs. Prev Qtr 18.75%
EPS Growth vs. Prev Year 64.86%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

APLT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -350.45%
Return-on-Assets % -103.09%
Profit Margin % -1,198.80%
Debt/Equity 0.00
Price/Sales 88.49
Price/Cash Flow N/A
Price/Book 12.41
Book Value/Share 0.63
Interest Coverage -4.81
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar